Termination

Helix Biotech Biosimilar mRNA Vaccines

  • UK Health Security Agency

UK12: Procurement termination notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-053927

Procurement identifier (OCID): ocds-h6vhtk-0585bd (view related notices)

Published 4 September 2025, 1:41pm



Contract 1. Helix Biotech Biosimilar mRNA Vaccines

This contract will not be signed.

Date of decision not to sign contract

2 September 2025

Reason for not signing contract

We are currently unable to modify the description on the Transparency Notice and therefore a termination notice has been issued for this procedure and a new UK5 Transparency Notice will be published with a modified description.

Supplier

Contract value

  • £150,000 excluding VAT
  • £180,000 including VAT

Contract dates

  • 8 September 2025 to 7 September 2027
  • 2 years

Supplier

Helix Biotech, Inc.

  • Public Procurement Organisation Number: PCMD-6995-GBGZ

1460 Breda Drive

Knoxville

37918

United States

Small or medium-sized enterprise (SME): Yes

Voluntary, community or social enterprise (VCSE): No

Contract 1. Helix Biotech Biosimilar mRNA Vaccines


Contracting authority

UK Health Security Agency

  • Public Procurement Organisation Number: PBMQ-7576-DVGW

10 South Colonnade

London

E14 4PU

United Kingdom

Region: UKI42 - Tower Hamlets

Organisation type: Public authority - central government